Christian Loyau

November 7, 2022

Christian Loyau graduated from the University of Paris in business, corporate and IP law. After 5 years of practicing in law firms in Denmark and France, Christian joined Digital Equipment Corporation, and Cap Gemini in France.

He served for 12 years as Legal Director for International Affairs for the French telecommunication company Matra Communication and was involved in the IPR group of ETSI from 1993 to 1996. He then served as General Counsel and Secretary of the Board of the French IT quoted company Bull for 14 years. Christian is now Director for Legal Affairs and Governance of the European Telecommunications Standards Institute (ETSI).

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

February 5, 2026

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent

Universities, Patents, and the Future of U.S. Competitiveness

December 15, 2025

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties

How Counterfeit Drugs Threaten U.S. Health and Innovation

November 19, 2025

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor